Solaris Endovascular Reports Positive Six-Month Interim Results for DEScover Trial
First Drug-Eluting Self-Expanding Covered Stent Demonstrates 95% Patency Through 6 Months; 100% Procedural Success and Zero 30-Day Device Related Adverse Events SAN FRANCISCO, CA, UNITED STATES, October 27, 2025 /EINPresswire.com/ -- Solaris …